000 01456 a2200397 4500
005 20250517024025.0
264 0 _c20160301
008 201603s 0 0 eng d
022 _a1096-1186
024 7 _a10.1016/j.phrs.2015.03.010
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGolpich, Mojtaba
245 0 0 _aGlycogen synthase kinase-3 beta (GSK-3β) signaling: Implications for Parkinson's disease.
_h[electronic resource]
260 _bPharmacological research
_cJul 2015
300 _a16-26 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't; Review
650 0 4 _aAntiparkinson Agents
_xpharmacology
650 0 4 _aEnzyme Inhibitors
_xpharmacology
650 0 4 _aGlycogen Synthase Kinase 3
_xantagonists & inhibitors
650 0 4 _aGlycogen Synthase Kinase 3 beta
650 0 4 _aHumans
650 0 4 _aInflammation
_xphysiopathology
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aSignal Transduction
_xdrug effects
700 1 _aAmini, Elham
700 1 _aHemmati, Fatemeh
700 1 _aIbrahim, Norlinah Mohamed
700 1 _aRahmani, Behrouz
700 1 _aMohamed, Zahurin
700 1 _aRaymond, Azman Ali
700 1 _aDargahi, Leila
700 1 _aGhasemi, Rasoul
700 1 _aAhmadiani, Abolhassan
773 0 _tPharmacological research
_gvol. 97
_gp. 16-26
856 4 0 _uhttps://doi.org/10.1016/j.phrs.2015.03.010
_zAvailable from publisher's website
999 _c24761878
_d24761878